PTSD is a debilitating mental disorder that may develop after experiencing or witnessing a life-threatening event. With appropriate care, treatment efficiency is variable and around 20% of the patients do not respond to psychological treatment. Complementary treatments are needed. as PTSD implied autonomic nervous system (ANS) dysfonction, complementary treatment focusing on ANS regulation, as welle as musicotherapy, may have an interest.
The aim is to evaluate the impact of musicotherapy on PTSD symptoms, and severity using a RCT Symptoms will be evaluated using questionaires (PCL and quality of life) severity will be measured using neurological soft signs assessment, connectomic functions and ANS regulation
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
15
receptive music therapy. The musical style of the session was chosen by the patient. The validated 'U' technique was employed.
Marion TROUSSELARD
Paris, IDF, France
change in PTSD symptoms
questionnaire Posttraumatic CheckList 5 (PCL5; threshold =33)
Time frame: change from PTSD symptoms at two months and at six months
change in neurological soft signs
questionnaire EPSID " Psychomotor assessment scale of neurological soft signs no threshold
Time frame: change from neurological soft signs at two months and at six months
change in effective connectomic
Magnetic Resonance Imaging
Time frame: change from effective connectomic at two months and at six months
Autonomous nervous system regulation
heart rate variability during 5 min at rest
Time frame: change from Autonomous nervous system regulation at two months and at six months
change in biological stress
blood cytokines, BDNF
Time frame: change from biological stress at two months and at six months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.